Enriching lipid nanovesicles with short‐chain glucosylceramide improves doxorubicin delivery and efficacy in solid tumors
Menno van Lummel(The Netherlands Cancer Institute), Gerben A. Koning(Università Cattolica del Sacro Cuore), Bilyana M. Dicheva(Erasmus MC), Marcel Verheij(Radboud University Nijmegen), Martin A. van der Valk(The Netherlands Cancer Institute), Timo L.M. ten Hagen(Erasmus MC), Alexander Eggermont(University Medical Center Utrecht), Stefan R. Vink(The Netherlands Cancer Institute), Debby Schipper(Erasmus MC), Wim J. van Blitterswijk(The Netherlands Cancer Institute), Robert Jan Veldman(The Netherlands Cancer Institute)
Cited by 60
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Genome-wide cell-free DNA fragmentation in patients with cancer
|Nature|2019|1.5k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941